Detalles de la búsqueda
1.
Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an observational cohort study.
Lancet Child Adolesc Health
; 6(1): 17-27, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34756190
Resultados
1 -
1
de 1
1
Próxima >
>>